CN105919931A - 一种稳定的盐酸法舒地尔注射液及其制备方法 - Google Patents
一种稳定的盐酸法舒地尔注射液及其制备方法 Download PDFInfo
- Publication number
- CN105919931A CN105919931A CN201610411554.XA CN201610411554A CN105919931A CN 105919931 A CN105919931 A CN 105919931A CN 201610411554 A CN201610411554 A CN 201610411554A CN 105919931 A CN105919931 A CN 105919931A
- Authority
- CN
- China
- Prior art keywords
- injection
- fasudil hydrochloride
- hydrochloride injection
- preparation
- carboxymethyl chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610411554.XA CN105919931B (zh) | 2016-06-12 | 2016-06-12 | 一种稳定的盐酸法舒地尔注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610411554.XA CN105919931B (zh) | 2016-06-12 | 2016-06-12 | 一种稳定的盐酸法舒地尔注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105919931A true CN105919931A (zh) | 2016-09-07 |
CN105919931B CN105919931B (zh) | 2017-10-27 |
Family
ID=56833690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610411554.XA Active CN105919931B (zh) | 2016-06-12 | 2016-06-12 | 一种稳定的盐酸法舒地尔注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105919931B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107854429A (zh) * | 2017-12-25 | 2018-03-30 | 南京正科医药股份有限公司 | 一种右旋酮洛芬氨丁三醇注射液及其制备工艺 |
CN108042487A (zh) * | 2018-01-26 | 2018-05-18 | 南京正科医药股份有限公司 | 一种右旋酮洛芬氨丁三醇注射剂及其制备方法 |
CN109568277A (zh) * | 2019-01-30 | 2019-04-05 | 成都欣捷高新技术开发股份有限公司 | 枸橼酸在制备帕瑞昔布钠冻干制剂组合物中的应用及其组合物和制备方法 |
CN113197848A (zh) * | 2021-05-24 | 2021-08-03 | 成都欣捷高新技术开发股份有限公司 | 一种重酒石酸间羟胺药物组合物及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104644551A (zh) * | 2015-02-06 | 2015-05-27 | 成都国弘医药有限公司 | 一种供注射用的含有盐酸法舒地尔的药物组合物 |
CN104840418A (zh) * | 2015-06-11 | 2015-08-19 | 山东新时代药业有限公司 | 一种盐酸法舒地尔注射液组合物及其制备方法 |
-
2016
- 2016-06-12 CN CN201610411554.XA patent/CN105919931B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104644551A (zh) * | 2015-02-06 | 2015-05-27 | 成都国弘医药有限公司 | 一种供注射用的含有盐酸法舒地尔的药物组合物 |
CN104840418A (zh) * | 2015-06-11 | 2015-08-19 | 山东新时代药业有限公司 | 一种盐酸法舒地尔注射液组合物及其制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107854429A (zh) * | 2017-12-25 | 2018-03-30 | 南京正科医药股份有限公司 | 一种右旋酮洛芬氨丁三醇注射液及其制备工艺 |
CN108042487A (zh) * | 2018-01-26 | 2018-05-18 | 南京正科医药股份有限公司 | 一种右旋酮洛芬氨丁三醇注射剂及其制备方法 |
CN109568277A (zh) * | 2019-01-30 | 2019-04-05 | 成都欣捷高新技术开发股份有限公司 | 枸橼酸在制备帕瑞昔布钠冻干制剂组合物中的应用及其组合物和制备方法 |
CN113197848A (zh) * | 2021-05-24 | 2021-08-03 | 成都欣捷高新技术开发股份有限公司 | 一种重酒石酸间羟胺药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105919931B (zh) | 2017-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105919931A (zh) | 一种稳定的盐酸法舒地尔注射液及其制备方法 | |
US10925877B2 (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
CN107441038B (zh) | 一种门冬氨酸鸟氨酸注射液及其制备方法 | |
CN105434373A (zh) | 一种注射用奥拉西坦冻干制剂及其制备方法 | |
CN101791310B (zh) | 长春西汀药物组合物及其制备方法 | |
CN105078909B (zh) | 一种注射用苯磺顺阿曲库铵冷冻干燥组合物及其制备方法 | |
CN101455631A (zh) | 环磷腺苷葡胺注射液及其制备工艺 | |
CN106959347B (zh) | 环磷腺苷葡胺注射液药物组合物的质控方法 | |
CN104840418A (zh) | 一种盐酸法舒地尔注射液组合物及其制备方法 | |
WO2021012686A1 (zh) | 盐酸纳洛酮注射液及其制备方法 | |
CN103239442A (zh) | 复方氨基酸注射液(18aa-v)的制备方法 | |
CN104069063B (zh) | 盐酸法舒地尔药物组合物及其制备方法 | |
CN104800172B (zh) | 注射用卡络磺钠粉针剂和制法 | |
CN104161732A (zh) | 注射用奥美拉唑钠及其制备方法和用途 | |
CN107019675B (zh) | 注射用环磷腺苷冻干粉针剂药物组合物及质控方法和制法 | |
WO2020029443A1 (zh) | 一种盐酸替罗非班注射液及其制备方法 | |
CN103735498B (zh) | 一种果糖二磷酸钠注射液的制备方法 | |
CN100408043C (zh) | 一种含虎杖苷的药物组合物及其应用 | |
CN106727287A (zh) | 依达拉奉和天然冰片的高浓度注射液 | |
WO2020011753A1 (en) | Compositions for therapeutic uses containing 5-htp and carbidopa | |
CN102258507A (zh) | 含有布洛芬的药物组合物及其制备方法和应用 | |
CN107184548B (zh) | 一种安全性高的左旋奥硝唑注射液及其制备方法 | |
CN110314132B (zh) | 一种门冬氨酸鸟氨酸注射液及其制备方法 | |
CN101491495A (zh) | 丹酚酸b镁注射剂、制备方法及应用 | |
CN108158989B (zh) | 一种盐酸氨溴索注射液组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 510623 Guangdong city of Guangzhou province Tianhe District Xian Cun Lu No. 5 room 3001-3006 Applicant after: Guangdong Zhong run Medicine Co.,Ltd. Address before: 1002-1004 room 69, Dongshan Plaza, No. 510000 martyrs Road, Guangzhou, Guangdong, Yuexiu District Applicant before: GUANGDONG SUNSHINE PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200310 Address after: 510623 Layer 3612, Kaihua International Center, No. 5 Xiancun Road, Tianhe District, Guangzhou City, Guangdong Province Patentee after: GUANGDONG ZHONGRUN DRUG DEVELOPMENT Co.,Ltd. Address before: 510623 Guangdong city of Guangzhou province Tianhe District Xian Cun Lu No. 5 room 3001-3006 Patentee before: Guangdong Zhong run Medicine Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room 601, Building A3, No. 11 Kaiyuan Avenue, Huangpu District, Guangzhou City, Guangdong Province, 510700 Patentee after: Zhongrun Pharmaceutical Co.,Ltd. Address before: 510623 3612, 36F, Kaihua International Center, No.5 Xiancun Road, Tianhe District, Guangzhou City, Guangdong Province Patentee before: GUANGDONG ZHONGRUN DRUG DEVELOPMENT Co.,Ltd. |
|
CP03 | Change of name, title or address |